Evaluation of BCL2 and BIM Expression and KRAS Mutations in Lung Adenocarcinoma

被引：0
|
作者：
Chi, A. W. [1 ]
Johnstone, S. E. [1 ]
Heist, R. [1 ]
Mark, E. [1 ]
Mino-Kenudson, M. [1 ]
机构：
[1] Massachusetts Gen Hosp, Boston, MA 02114 USA
来源：
MODERN PATHOLOGY | 2014年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1951
引用
收藏
页码：475A / 475A
页数：1
相关论文
共 50 条
  • [1] Evaluation of BCL2 and BIM Expression and KRAS Mutations in Lung Adenocarcinoma
    Chi, A. W.
    Johnstone, S. E.
    Heist, R.
    Mark, E.
    Mino-Kenudson, M.
    LABORATORY INVESTIGATION, 2014, 94 : 475A - 475A
  • [2] Impact of BCL2 Mutations to BCL2 Protein Expression in B-Cell Lymphoma
    Baik, Jeeyeon
    Isgor, Irem
    Aypar, Umut
    Dogan, Ahmet
    LABORATORY INVESTIGATION, 2023, 103 (03) : S1096 - S1097
  • [3] Evaluation of KRAS Concomitant Mutations in Advanced Lung Adenocarcinoma Patients
    Aran, Veronica
    Zalis, Mariano
    Montella, Tatiane
    de Sousa, Carlos Augusto Moreira
    Ferrari, Bruno L.
    Gil Ferreira, Carlos
    MEDICINA-LITHUANIA, 2021, 57 (10):
  • [4] Deuterium Depleted Water Effects on Survival of Lung Cancer Patients and Expression of Kras, Bcl2, and Myc Genes in Mouse Lung
    Gyoengyi, Zoltan
    Budan, Ferenc
    Szabo, Istvan
    Ember, Istvan
    Kiss, Istvan
    Krempels, Krisztina
    Somlyai, Ildiko
    Somlyai, Gabor
    NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2013, 65 (02): : 240 - 246
  • [5] CLINICOPATHOLOGICAL FEATURES OF LUNG ADENOCARCINOMA WITH KRAS MUTATIONS
    Kakegawa, Seiichi
    Shimizu, Kimihiro
    Nakano, Tetsuhiro
    Sugano, Masayuki
    Miyamae, Yohei
    Kamiyoshihara, Mitsuhiro
    Kawashima, Osamu
    Takeyoshi, Izumi
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S986 - S986
  • [6] KRAS and EGFR mutations coexisting in lung adenocarcinoma
    Vitor Sousa
    Ana Alarcão
    Patricia Couceiro
    Maria R Silva
    Maria J d’Aguiar
    Lia Teixeira
    Lina Carvalho
    BMC Proceedings, 4 (Suppl 2)
  • [7] Clinicopathological Features of Lung Adenocarcinoma With KRAS Mutations
    Kakegawa, Seiichi
    Shimizu, Kimihiro
    Sugano, Masayuki
    Miyamae, Yohei
    Kaira, Kyoichi
    Araki, Takuya
    Nakano, Tetsuhiro
    Kamiyoshihara, Mitsuhiro
    Kawashima, Osamu
    Takeyoshi, Izumi
    CANCER, 2011, 117 (18) : 4257 - 4266
  • [8] KRAS mutations in 1355 Italian patients with lung adenocarcinoma
    Paliogiannis, P.
    Lobrano, R.
    Colombino, M.
    Sini, M. C.
    Fara, A.
    Fedeli, M. A.
    Palmieri, G.
    Cossu, A.
    VIRCHOWS ARCHIV, 2022, 481 (SUPPL 1) : S141 - S142
  • [9] High mesothelin expression in advanced lung adenocarcinoma is associated with KRAS mutations and a poor prognosis
    Thomas, Anish
    Chen, Yuanbin
    Steinberg, Seth M.
    Luo, Ji
    Pack, Svetlana
    Raffeld, Mark
    Abdullaev, Zied
    Alewine, Christine
    Rajan, Arun
    Giaccone, Giuseppe
    Pastan, Ira
    Miettinen, Markku
    Hassan, Raffit
    ONCOTARGET, 2015, 6 (13) : 11694 - 11702
  • [10] Prognostic value of loss of heterozygosity and KRAS2 mutations in lung adenocarcinoma
    De Gregorio, L
    Manenti, G
    Incarbone, M
    Pilotti, S
    Pastorino, U
    Pierotti, MA
    Dragani, TA
    INTERNATIONAL JOURNAL OF CANCER, 1998, 79 (03) : 269 - 272
12345